Hefei Lifeon Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hefei Lifeon Pharmaceutical Co., Ltd.

Why is Hefei Lifeon Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -9.44% and Operating profit at -6.84% over the last 5 years

Negative results in Sep 25

INTEREST(HY) At CNY 1.14 MM has Grown at 63.3%
ROCE(HY) Lowest at 9.21%
DEBT-EQUITY RATIO (HY) Highest at -18.7 %

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hefei Lifeon Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Hefei Lifeon Pharmaceutical Co., Ltd.

-100.0%

0.46

52.29%

China Shanghai Composite

16.01%

1.07

14.99%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-9.44%

EBIT Growth (5y)

-6.84%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

0.97

Tax Ratio

12.70%

Dividend Payout Ratio

59.64%

Pledged Shares

Institutional Holding

ROCE (avg)

17.15%

ROE (avg)

12.11%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.91

EV to EBIT

35.87

EV to EBITDA

21.07

EV to Capital Employed

3.33

EV to Sales

3.30

PEG Ratio

Dividend Yield

1.08%

ROCE (Latest)

9.27%

ROE (Latest)

9.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 857.13 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DIVIDEND PAYOUT RATIO(Y)

Highest at 123.84%

RAW MATERIAL COST(Y)

Fallen by -1.76% (YoY

-19What is not working for the Company

INTEREST(HY)

At CNY 1.14 MM has Grown at 63.3%

ROCE(HY)

Lowest at 9.21%

DEBT-EQUITY RATIO (HY)

Highest at -18.7 %

OPERATING PROFIT(Q)

Lowest at CNY 28.18 MM

NET SALES(Q)

Lowest at CNY 348.25 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.09 %

NET PROFIT(Q)

Lowest at CNY 30.76 MM

EPS(Q)

Lowest at CNY 0.16

Here's what is working for Hefei Lifeon Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 857.13 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Dividend Payout Ratio

Highest at 123.84%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -1.76% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hefei Lifeon Pharmaceutical Co., Ltd.

Interest

At CNY 1.14 MM has Grown at 63.3%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 28.18 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Debt-Equity Ratio

Highest at -18.7 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at CNY 348.25 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit Margin

Lowest at 8.09 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at CNY 30.76 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

Fallen at -26.3%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.16

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)